Anti-CD20 mAbs were originally created to treat B cell proliferative diseases such as non-Hodgkin's lymphoma and chronic ...

Compared with wild-type mice, HEM1-deficient mice had increased numbers of neutrophils, which showed defects in both chemotaxis and phagocytosis; decreased phagocytosis by the macrophages of these ...